– UK, Guildford – Ergomed plc (LON: ERGO), a company focused on providing specialized services to the pharmaceutical industry, today announced the appointment of John Dawson CBE as Senior Independent Director with immediate effect.
Mr. Dawson has served as an independent Non-Executive Director and Chair of the company’s Audit Committee since March 2022.
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmaco-vigilance, and medical information. Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand, a full range of high-quality clinical research and trial management services under the Ergomed brand, and mission-critical regulatory compliance and consulting services under the ADAMAS brand.
For more information: https://ergomedplc.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.